HomeCompareICABF vs MRK

ICABF vs MRK: Dividend Comparison 2026

ICABF yields 285714.29% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ICABF wins by $1.734986541242196e+31M in total portfolio value
10 years
ICABF
ICABF
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full ICABF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ICABF vs MRK

📍 ICABF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodICABFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ICABF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ICABF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ICABF
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ICABF beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ICABF + MRK for your $10,000?

ICABF: 50%MRK: 50%
100% MRK50/50100% ICABF
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ICABF
No analyst data
Altman Z
-20.2
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ICABF buys
0
MRK buys
0
No recent congressional trades found for ICABF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricICABFMRK
Forward yield285714.29%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.734986541242196e+31M$56.8K
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$1.734908400352195e+31M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ICABF vs MRK ($10,000, DRIP)

YearICABF PortfolioICABF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$28,582,129$28,571,428.57$11,206$366.19+$28.57MICABF
2$76,351,353,429$76,320,770,551.21$12,650$502.35+$76351.34MICABF
3$190,619,493,207,524$190,537,797,259,355.30$14,407$694.19+$190619493.19MICABF
4$444,781,927,427,195,200$444,577,964,569,463,100.00$16,585$967.82+$444781927427.18MICABF
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$19,342$1,363.89+$969967353346567.13MICABF
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$22,913$1,947.19+$1976961629315092992.00MICABF
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$27,662$2,823.89+$3.765923944594039e+21MICABF
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$34,159$4,173.35+$6.704681437057683e+24MICABF
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$43,337$6,308.80+$1.1156275836497015e+28MICABF
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$56,776$9,798.13+$1.734986541242196e+31MICABF

ICABF vs MRK: Complete Analysis 2026

ICABFStock

i-CABLE Communications Limited, an investment holding company, provides integrated communications services in Hong Kong. The company operates through Media and Telecommunications segments. The Media segment offers television subscription, domestic free television program, advertising, channel carriage, television relay, program licensing, theatrical release, and other related services. The Telecommunications segment includes operations related to broadband internet access, portal operations, telephony, network leasing, network construction, and mobile agency services, as well as other related businesses. The company owns and operates wireline telecommunications network, which provides media and telecommunications services to approximately two million households. The company also produces television and multimedia content focusing on news, information, sports, and entertainment. In addition, it provides technical services; and film production, distribution, and licensing services. The company was incorporated in 1999 and is based in Tsuen Wan, Hong Kong.

Full ICABF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ICABF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ICABF vs SCHDICABF vs JEPIICABF vs OICABF vs KOICABF vs MAINICABF vs JNJICABF vs ABBVICABF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.